View in EDS PDF Full Text

PCSK9 inhibitor Evolocumab alleviates atherosclerosis progression by suppressing endothelial cell injury via the ROS/MAPK pathway.

Saved in:
Bibliographic Details
Title: PCSK9 inhibitor Evolocumab alleviates atherosclerosis progression by suppressing endothelial cell injury via the ROS/MAPK pathway.
Authors: Ma M; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China., Liu F; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China., Yin X; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China., Yue J; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China., Duan Y; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China., Tang J; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
Source: General physiology and biophysics [Gen Physiol Biophys] 2026 Mar; Vol. 45 (2), pp. 153-165.
Publication Type: Journal Article
Journal Info: Publisher: Ústav molekulárnej fyziológie a genetiky SAV Country of Publication: Slovakia NLM ID: 8400604 Publication Model: Print Cited Medium: Print ISSN: 0231-5882 (Print) Linking ISSN: 02315882 NLM ISO Abbreviation: Gen Physiol Biophys Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42281501
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PCSK9 inhibitor Evolocumab alleviates atherosclerosis progression by suppressing endothelial cell injury via the ROS/MAPK pathway.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ma+M%22">Ma M</searchLink>; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.<br /><searchLink fieldCode="AU" term="%22Liu+F%22">Liu F</searchLink>; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.<br /><searchLink fieldCode="AU" term="%22Yin+X%22">Yin X</searchLink>; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.<br /><searchLink fieldCode="AU" term="%22Yue+J%22">Yue J</searchLink>; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.<br /><searchLink fieldCode="AU" term="%22Duan+Y%22">Duan Y</searchLink>; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.<br /><searchLink fieldCode="AU" term="%22Tang+J%22">Tang J</searchLink>; Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228400604%22">General physiology and biophysics</searchLink> [Gen Physiol Biophys] 2026 Mar; Vol. 45 (2), pp. 153-165.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ústav+molekulárnej+fyziológie+a+genetiky+SAV%22">Ústav molekulárnej fyziológie a genetiky SAV </searchLink><i>Country of Publication: </i>Slovakia <i>NLM ID: </i>8400604 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0231-5882 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202315882%22">02315882 </searchLink><i>NLM ISO Abbreviation: </i>Gen Physiol Biophys <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42281501
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4149/gpb_2025043
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 153
    Titles:
      – TitleFull: PCSK9 inhibitor Evolocumab alleviates atherosclerosis progression by suppressing endothelial cell injury via the ROS/MAPK pathway.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ma M
      – PersonEntity:
          Name:
            NameFull: Liu F
      – PersonEntity:
          Name:
            NameFull: Yin X
      – PersonEntity:
          Name:
            NameFull: Yue J
      – PersonEntity:
          Name:
            NameFull: Duan Y
      – PersonEntity:
          Name:
            NameFull: Tang J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 0231-5882
          Numbering:
            – Type: volume
              Value: 45
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: General physiology and biophysics
              Type: main
ResultId 1